首页> 美国卫生研究院文献>Critical Care >Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects
【2h】

Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects

机译:通过部分体外循环灌注对绵羊进行体外膜肺通气施用硫化氢:关于代谢和血管舒缩作用的概念研究的证明

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionAlthough inhalation of 80 parts per million (ppm) of hydrogen sulfide (H2S) reduces metabolism in mice, doses higher than 200 ppm of H2S were required to depress metabolism in rats. We therefore hypothesized that higher concentrations of H2S are required to reduce metabolism in larger mammals and humans. To avoid the potential pulmonary toxicity of H2S inhalation at high concentrations, we investigated whether administering H2S via ventilation of an extracorporeal membrane lung (ECML) would provide means to manipulate the metabolic rate in sheep.
机译:简介虽然吸入百万分之80的硫化氢(H2S)会降低小鼠的新陈代谢,但需要200 ppm以上的H2S剂量才能抑制大鼠的新陈代谢。因此,我们假设需要更大浓度的H2S才能减少大型哺乳动物和人类的新陈代谢。为了避免高浓度吸入H2S的潜在肺毒性,我们调查了通过体外膜肺(ECML)的通气施用H2S是否将提供控制绵羊代谢率的手段。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号